Please login to read the full article.
Scrip Regulatory Affairs
Singapore mandates licensing of moderate to high-risk devices
26 August 2010
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Singapore to ease registration requirements for most Class A and B medical devices
- Singapore plans to introduce new framework for medtech trials in 2012
- UK questions key facets of EU anti-counterfeiting plan
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
